Opportunistic Infections Citation List: September 11 - September 24, 2015

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)

1. In Vitro and in Vivo Evaluation of Synergism between Anti-tubercular Spectinamides and Non-classical Tuberculosis Antibiotics. Bruhn, D.F., M.S. Scherman, J. Liu, D. Scherbakov, B. Meibohm, E.C. Bottger, A.J. Lenaerts, and R.E. Lee. Scientific Reports, 2015. 5(13985): 10pp. PMID[26365087].

[PubMed]. OI_0911-092415.

2. Synthesis and Biological Evaluation of Phaitanthrin Congeners as Anti-mycobacterial Agents. Kamal, A., B.V. Reddy, B. Sridevi, A. Ravikumar, A. Venkateswarlu, G. Sravanthi, J.P. Sridevi, P. Yogeeswari, and D. Sriram. Bioorganic & Medicinal Chemistry Letters, 2015. 25(18): p. 3867-3872. PMID[26253635].

[PubMed]. OI_0911-092415.

3. Linked Pyridinyl-thiadiazoles: Design and Synthesis as Potential Candidate for Treatment of XDR and MDR Tuberculosis. Mahajan, N.S. and S.C. Dhawale. European Journal of Medicinal Chemistry, 2015. 102: p. 243-248. PMID[26280920].

[PubMed]. OI_0911-092415.

4. Synthesis of Arabinose glycosyl sulfamides as Potential Inhibitors of Mycobacterial Cell Wall Biosynthesis. Suthagar, K., A.J. Watson, B.L. Wilkinson, and A.J. Fairbanks. European Journal of Medicinal Chemistry, 2015. 102: p. 153-166. PMID[26263247].

[PubMed]. OI_0911-092415.

5. Biarylmethoxy 2-nitroimidazooxazine Antituberculosis Agents: Effects of Proximal Ring Substitution and Linker Reversal on Metabolism and Efficacy. Thompson, A.M., A. Blaser, B.D. Palmer, S.G. Franzblau, B. Wan, Y. Wang, Z. Ma, and W.A. Denny. Bioorganic & Medicinal Chemistry Letters, 2015. 25(18): p. 3804-3809. PMID[26253632].

[PubMed]. OI_0911-092415.

Citations from the ISI Web of Knowledge Listings for O.I.

6. Synthesis and Bio-evaluation of Phenothiazine Derivatives as New Anti-tuberculosis Agents. He, C.X., H. Meng, X. Zhang, H.Q. Cui, and D.L. Yin. Chinese Chemical Letters, 2015. 26(8): p. 951-954. ISI[000360516700007].

[WOS]. OI_0911-092415.